Here are five things to know:
1. Mr. Feinstein noted his decision to resign was due to his other responsibilities, including his role as the managing partner at Vesey Street Capital Partners.
2. He confirmed “his resignation was not the result of any disagreement with the Company with respect to its financial and auditing policies, operations or practices.”
3. While on the board, he served as chair of the Audit and Compliance Committee and as a member of the Governance and Nominating Committee.
4. Terry Allison Rappuhn will fill the vacancy. She served as a director of Akorn, a publicly held specialty pharmaceutical company, since 2015.
5. Ms. Rappuhn served as senior vice president and CFO of Quorum Health Group from 1999 to 2001, after which she served on a number of boards.
More articles on leadership:
Sen. Elizabeth Warren, 3 others ask OIG to probe scheduled HealthCare.gov maintenance
Viewpoint: $60B in improper Medicare payments deserves greater government attention
HHS releases strategic plan for 2018-22: 5 things to know
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.